These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 34360845)

  • 1. Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra.
    Conti P; Pregliasco FE; Bellomo RG; Gallenga CE; Caraffa A; Kritas SK; Lauritano D; Ronconi G
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL-37.
    Conti P; Gallenga CE; Ronconi G; Caraffa A; Kritas SK
    Dermatol Ther; 2019 Jul; 32(4):e12943. PubMed ID: 31012218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1 family cytokines and mast cells: activation and inhibition.
    Gallenga CE; Pandolfi F; Caraffa Al; Kritas SK; Ronconi G; Toniato E; Martinotti S; Conti P
    J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):1-6. PubMed ID: 30656901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
    Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.
    Tettamanti L; Kritas SK; Gallenga CE; D'Ovidio C; Mastrangelo F; Ronconi G; Caraffa Al; Toniato E; Conti P
    J Biol Regul Homeost Agents; 2018; 32(5):1061-1065. PubMed ID: 30334399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-36 receptor antagonistic antibodies inhibit inflammatory responses in preclinical models of psoriasiform dermatitis.
    Su Z; Paulsboe S; Wetter J; Salte K; Kannan A; Mathew S; Horowitz A; Gerstein C; Namovic M; Todorović V; Seagal J; Edelmayer RM; Viner M; Rinaldi L; Zhou L; Leys L; Huang S; Wang L; Sadhukhan R; Honore P; McGaraughty S; Scott VE
    Exp Dermatol; 2019 Feb; 28(2):113-120. PubMed ID: 30417427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help?
    Lauritano D; Ronconi G; Caraffa A; Enrica Gallenga C; Kritas SK; Di Emidio P; Martinotti S; Tetè G; Ross R; Conti P
    Med Hypotheses; 2020 Jun; 139():109687. PubMed ID: 32259663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of the IL-36 cytokine family as novel targets for inflammatory diseases.
    Walsh PT; Fallon PG
    Ann N Y Acad Sci; 2018 Apr; 1417(1):23-34. PubMed ID: 27783881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia and mast cells generate proinflammatory cytokines in the brain and worsen inflammatory state: Suppressor effect of IL-37.
    Conti P; Lauritano D; Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Martinotti S
    Eur J Pharmacol; 2020 May; 875():173035. PubMed ID: 32097657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR-T cell therapy causes inflammation by IL-1 which activates inflammatory cytokine mast cells: anti-inflammatory role of IL-37.
    Caraffa A; Gallenga CE; Kritas SK; Ronconi G; Di Emidio P; Conti P
    J Biol Regul Homeost Agents; 2019; 33(6):1981-1985. PubMed ID: 31920059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression in migraine: Role of mast cells and pro-inflammatory and anti-inflammatory cytokines.
    Conti P; D'Ovidio C; Conti C; Gallenga CE; Lauritano D; Caraffa A; Kritas SK; Ronconi G
    Eur J Pharmacol; 2019 Feb; 844():87-94. PubMed ID: 30529470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Mast Cells Mediate Low-Grade Inflammation in Type 2 Diabetes: Interleukin-37 Could Be Beneficial.
    Conti P; Ronconi G; Kritas SK; Caraffa A; Theoharides TC
    Can J Diabetes; 2018 Oct; 42(5):568-573. PubMed ID: 29885882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-33 induces skin inflammation with mast cell and neutrophil activation.
    Hueber AJ; Alves-Filho JC; Asquith DL; Michels C; Millar NL; Reilly JH; Graham GJ; Liew FY; Miller AM; McInnes IB
    Eur J Immunol; 2011 Aug; 41(8):2229-37. PubMed ID: 21674479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis.
    Zhang J; Lin Y; Li C; Zhang X; Cheng L; Dai L; Wang Y; Wang F; Shi G; Li Y; Yang Q; Cui X; Liu Y; Wang H; Zhang S; Yang Y; Xiang R; Li J; Yu D; Wei Y; Deng H
    J Immunol; 2016 Sep; 197(6):2131-44. PubMed ID: 27527600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
    Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
    J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast Cell Cytokines in Acute and Chronic Gingival Tissue Inflammation: Role of IL-33 and IL-37.
    Trimarchi M; Lauritano D; Ronconi G; Caraffa A; Gallenga CE; Frydas I; Kritas SK; Calvisi V; Conti P
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.